Does Pooping Cause You to Lose Weight? The Surprising Truth About Bowel Movements and Body Mass

Reviewed by FormBlends Medical Team · Last updated September 5, 2026 · 17 sources cited

Key Takeaways

• Bowel movements reduce scale weight temporarily (a 2015 systematic review puts median output at about 128 grams, or 0.28 pounds, a day across 1.2 movements) but do not reduce body fat or alter body composition
• The weight lost is undigested food residue, water, bacteria, and cellular debris, all of which your body replaces within 24 hours through normal eating and drinking
• GLP-1 medications like semaglutide and tirzepatide change bowel movement frequency and volume, which affects daily scale fluctuations but not the rate of actual fat loss
• Constipation can mask fat loss on the scale by the weight of the stool retained: at the published median of about 128 grams a day, five days without a movement is roughly 640 grams, or 1.4 pounds, before any water shift, enough to create the false impression that treatment isn't working

The short answer

Pooping causes temporary weight loss on the scale (median stool output is about 128 grams, or 0.28 pounds, a day across 1.2 movements, per a 2015 systematic review), but this is waste elimination, not fat loss. The weight returns as you eat and drink throughout the day. True weight loss requires burning stored fat through caloric deficit, which happens independently of bowel movement frequency.

Table of contents

1. What most articles get wrong about poop and weight
2. The composition of a bowel movement: what you're actually losing
3. The math: how much does poop weigh?
4. Why the scale drops after pooping (and why it comes back)
5. The difference between scale weight and fat loss
6. How GLP-1 medications change the bowel movement equation
7. The constipation masking effect: when poop retention hides fat loss
8. The decision tree: when scale changes mean something real
9. What daily weigh-ins actually measure (and when to ignore them)
10. The 72-hour body mass stability model
11. When bowel changes signal a problem worth addressing
12. Correction (September 2026)
13. GLP-1 bowel effects by the label
14. Constipation defined and when to call
15. FAQ

What most articles get wrong about poop and weight

The dominant narrative online is that pooping causes "weight loss" in a meaningful sense. Search results are filled with articles claiming you can "lose up to 2 pounds" by having a bowel movement, often presented as if this contributes to fat loss goals.

This is categorically wrong. The error conflates two unrelated measurements: waste elimination (a temporary change in total body mass) and fat oxidation (a permanent change in stored energy). The scale measures both, which creates confusion.

Here's the specific mistake: most articles treat all scale movement as equivalent. A 1-pound drop from pooping is presented the same way as a 1-pound drop from a week of caloric deficit. These are not the same phenomenon. One is reversible within hours. The other represents actual tissue loss.

The correction: bowel movements affect hydration status and gut contents, both of which contribute to scale weight but not to body composition. Stool is water, undigested fiber, bacteria and shed cells (StatPearls, Physiology, Defecation, updated November 13, 2023); none of it is adipose tissue, so passing it cannot change fat mass. Correction, September 2026: an earlier version cited a 2023 DEXA study (Müller et al., 47 participants). No such study exists in PubMed and it has been removed.

The practical implication: if you weigh yourself before and after a bowel movement, the difference tells you how much waste you eliminated. It tells you nothing about whether your weight-loss program is working.

The composition of a bowel movement: what you're actually losing

A typical bowel movement consists of:

• Water: about three quarters by weight. A 2015 systematic review (Rose et al.) puts the median at 74.6% water; StatPearls gives 75% water and 25% solids.
• Undigested food and fiber: about 30% of the solids (StatPearls). Cellulose, lignin, resistant starch, and other plant materials humans can't break down.
• Bacteria (dead and alive): about 30% of the solids per StatPearls; Rose et al. put bacterial biomass at 25 to 54% of dry solids.
• Inorganic material: 10 to 20% of the solids (StatPearls).
• Fat: 10 to 20% of the solids, and protein 2 to 3% (StatPearls). Bile pigments, the breakdown products of hemoglobin, give stool its brown color.

None of these components are adipose tissue. When you eliminate stool, you're removing material your body has already decided not to absorb. The caloric value of stool is near zero because anything with meaningful energy content was absorbed in the small intestine.

The water portion is the most variable: it rises with looser stool and falls with harder stool, and the 74.6% figure is a population median. This variability is why stool weight fluctuates day to day even when food intake is constant.

The math: how much does poop weigh?

Published studies on fecal weight in healthy adults:

Study	Population	Average daily stool weight	Range
Rose et al., Critical Reviews in Environmental Science and Technology, 2015 (systematic review)	Pooled published studies worldwide	Median 128 grams/day wet (29 grams dry); 1.20 defecations/day; 74.6% water	Wet mass about twice as high in high-fiber, low-income countries
Cummings et al., Gastroenterology, 1992	220 healthy UK adults	Median 106 grams/day (men 104, women 99)	17% of women vs 1% of men passed under 50 grams/day; worldwide population averages 72 to 470 grams/day
Stephen et al., British Journal of Nutrition, 1986	30 healthy UK subjects	Men 162 grams/day, women 83 grams/day	Stool weight rose with wheat fibre dose
Burkitt et al., Lancet, 1972	High-fiber populations	Higher than Western populations; the paper's figures could not be verified for this update and are not reproduced	See Cummings 1992 for population range

Converting to pounds: 100 grams is 0.22 pounds, so the 128-gram median is 0.28 pounds a day and the UK median of 106 grams is 0.23 pounds, usually in one or two movements (1.20 a day in Rose 2015).

Individual bowel movement weight depends on:

• Fiber intake. Higher fiber means more undigested residue and more stool bulk. Rose 2015 found wet stool mass about twice as high in high-fiber, low-income countries, Cummings 1992 put worldwide population averages at 72 to 470 grams a day, and Stephen 1986 measured a dose-related rise with wheat fibre.
• Hydration status. Dehydration pulls water out of stool, making it denser and smaller.
• Transit time. Faster transit (as with GLP-1 medications or irritable bowel syndrome) means more water retention in stool.
• Meal size and frequency. Larger meals produce more waste.

The practical figure: with a median of 128 grams a day across 1.2 movements (Rose 2015), a typical single movement is on the order of 100 grams, about a quarter of a pound. Several days of retention add up arithmetically. No published study reports the weight of a single post-constipation movement, so earlier figures for that have been removed.

Why the scale drops after pooping (and why it comes back)

The immediate post-bowel-movement scale drop is real but temporary. Here's the 24-hour cycle:

Morning (fasted state, post-bowel movement): You weigh the least you'll weigh all day. Overnight you lost water through breathing and perspiration, you haven't eaten for hours, and if you have a bowel movement before weighing you've eliminated roughly another quarter pound (Rose 2015 median).

Through the day: Every drink and meal adds its physical mass to the scale until it is absorbed or passed, so weight climbs from morning to evening. This is entirely normal and not fat gain.

Overnight: You lose water through respiration (you exhale water vapor and CO₂) and perspiration. You don't eat or drink, so gut contents decrease as digestion continues. Correction, September 2026: the pound figures previously attached to each phase of this cycle were not sourced and have been removed.

The cycle repeats. The bowel movement is one part of this daily fluctuation, not a special weight-loss event.

Correction, September 2026: an earlier version cited a 2021 continuous-weighing study (Edholm et al., 23 adults) with 3 to 6 pound daily swings and a 5 to 15% share for bowel movements. No such paper exists in PubMed and it has been removed. What can be said from the published stool data is that a median day's stool (128 grams) is a small fraction of the food and fluid an adult takes in and passes through each day.

The difference between scale weight and fat loss

Scale weight is the sum of:

• Fat mass (adipose tissue)
• Lean mass (muscle, organs, bone)
• Total body water (intracellular, extracellular, blood volume)
• Gut contents (food in transit, stool)
• Glycogen stores (carbohydrate stored in liver and muscle, bound to water)

Fat loss is a change in one component: adipose tissue. The scale can't distinguish between these components. A 2-pound overnight drop might be:

• 0.25 pounds of stool
• 0.75 pounds of water loss
• 1 pound of glycogen depletion (common after low-carb meals)
• 0 pounds of fat loss

Or it might be:

• 0.5 pounds of stool
• 1 pound of water loss
• 0.3 pounds of fat loss
• 0.2 pounds of muscle loss (if in severe caloric deficit without adequate protein)

The scale can't tell you which. This is why single-day weigh-ins are nearly useless for tracking fat loss. The signal (fat change) is smaller than the noise (water, gut contents, glycogen).

The solution: trend-based tracking. Weigh daily at the same time (morning, post-bowel movement, fasted), then calculate a 7-day rolling average. The average smooths out water and gut content fluctuations, leaving the fat loss signal visible.

How GLP-1 medications change the bowel movement equation

GLP-1 receptor agonists (semaglutide, tirzepatide, liraglutide) alter bowel movement patterns in two ways:

Mechanism 1: Delayed gastric emptying. GLP-1 medications slow the rate at which food leaves the stomach, and the effect is largest at the start. Urva and colleagues (Diabetes, Obesity and Metabolism 2020) showed tirzepatide transiently delays gastric emptying much like long-acting GLP-1 receptor agonists, with the delay fading over time; the labels report that after the first 5 mg dose tirzepatide cut peak acetaminophen exposure by about 50% and that by week 4 there was no meaningful impact. Correction, September 2026: gastric-emptying half-times of 90 to 120 minutes and 3 to 4 hours attributed to a 2023 Diabetes Care paper were not sourced and have been removed.

Mechanism 2: Altered colonic motility. GLP-1 receptors exist throughout the GI tract, including the colon. Activation affects peristalsis (the wave-like muscle contractions that move stool). Some patients experience faster transit (diarrhea), others slower (constipation). The direction depends on baseline gut motility and individual receptor sensitivity.

The published rates come from the labels, not from FormBlends data (an earlier version cited internal percentages that were not drawn from an audited dataset; they have been removed). In the Zepbound label's pooled placebo-controlled trials (revised 08/2026), diarrhea was reported by 19%, 21% and 23% of patients at 5, 10 and 15 mg versus 8% on placebo, and constipation by 17%, 14% and 11% versus 5%. In the Mounjaro label's pooled type 2 diabetes trials, diarrhea was 12% to 17% versus 9% and constipation 6% to 7% versus 1%.

The scale impact: patients with GLP-1-induced diarrhea can see exaggerated morning scale drops because looser stool carries more water, which creates a false impression of accelerated fat loss. Patients with constipation see the opposite: scale weight stays elevated by the mass of retained stool despite ongoing fat loss, creating the false impression that treatment isn't working.

The correction: if you're on a GLP-1 medication and your bowel habits have changed, expect scale weight to be less reliable while your gut adapts, which the labels describe as mostly during dose escalation. Focus on non-scale indicators: how clothes fit, waist circumference, progress photos, energy levels.

The constipation masking effect: when poop retention hides fat loss

Constipation is defined by the National Institute of Diabetes and Digestive and Kidney Diseases as fewer than three bowel movements a week, or stools that are hard, dry or difficult to pass; it affects about 16 of every 100 US adults and 33 of every 100 aged 60 and over. On tirzepatide, the Zepbound label (revised 08/2026) reports constipation in 17%, 14% and 11% of patients at 5, 10 and 15 mg versus 5% on placebo in the pooled weight-management trials; the Mounjaro label reports 6% to 7% versus 1% in type 2 diabetes. Correction, September 2026: a 15 to 30% range attributed to SURMOUNT-1 did not match the label and has been replaced.

When stool accumulates in the colon over several days, it adds measurable weight. A patient who normally has daily bowel movements (eliminating 0.25 pounds per day) but goes 5 days without a movement is retaining roughly 1.25 pounds of stool. Any water held with that stool adds to it, but no published figure quantifies the total, so an earlier estimate has been removed.

This creates a frustrating scenario: the patient is in caloric deficit, burning fat, losing actual body mass, but the scale doesn't move (or moves up) because stool retention offsets fat loss.

The pattern resolves suddenly. When the patient finally has a bowel movement, the scale drops by the mass of what was retained, all at once. This looks like sudden fat loss but is actually the release of retained waste.

When to act on constipation:

• Day 1 to 2 without a bowel movement: Normal variation. No action needed if you feel comfortable.
• Fewer than three movements in a week, or hard, dry or difficult stools: This meets the NIDDK definition of constipation. Fluids, dietary fiber and walking are the usual first steps; ask your provider or pharmacist before adding any stool softener or laxative, and tell them which GLP-1 medication and dose you are on.
• No movement for several days with cramping, or any red-flag symptom listed below: Contact your provider the same day.

Correction, September 2026: an earlier version of this section gave specific over-the-counter product doses by day. Those were not drawn from a clinical guideline and have been removed.

The goal is to prevent the masking effect from distorting your perception of treatment progress. Constipation is manageable, but ignoring it for weeks creates unnecessary scale confusion.

The decision tree: when scale changes mean something real

Use this framework to interpret daily scale fluctuations:

If scale weight drops 0.5 to 2 pounds overnight:

• Did you have a bowel movement this morning but not yesterday morning? → Likely explanation: stool elimination.
• Did you eat a low-carb dinner last night? → Likely explanation: glycogen and water depletion.
• Did you drink less water than usual yesterday? → Likely explanation: dehydration.
• None of the above, and you're in week 2+ of consistent caloric deficit? → Possible fat loss, but confirm with 7-day trend.

If scale weight increases 1 to 3 pounds overnight:

• Did you eat a high-sodium meal last night (restaurant food, processed food)? → Likely explanation: water retention from sodium.
• Did you start or intensify strength training in the past 48 hours? → Likely explanation: muscle inflammation and glycogen replenishment.
• Are you within 7 days of menstruation? → Likely explanation: hormonal water retention.
• Did you skip a bowel movement today? → Likely explanation: stool retention.

If scale weight is unchanged for 7+ days despite caloric deficit:

• Are you constipated (fewer than 3 movements in the past week)? → Address constipation first.
• Are you weighing at inconsistent times (sometimes fasted, sometimes post-meal)? → Standardize weigh-in timing.
• Are you in a true caloric deficit, verified by food logging? → If yes, this is a plateau worth discussing with your provider. If no, tighten dietary adherence.

If 7-day rolling average drops 0.5 to 2 pounds per week:

• A gradual, sustained decline in the 7-day average is the fat-loss signal. The rate varies by person, medication and dose; bowel movements are irrelevant to this trend.

What daily weigh-ins actually measure (and when to ignore them)

Daily weigh-ins are useful for trend tracking but misleading for day-to-day interpretation. The single-day measurement is dominated by noise:

Component	Contribution to daily scale fluctuation
Water retention/loss (sodium, hormones, exercise)	Usually the largest day-to-day driver
Gut contents (food in transit, stool)	Stool alone: median about 128 grams (0.28 pounds) a day (Rose 2015), plus whatever food and fluid is in transit
Glycogen stores (carb intake variation)	Varies with carbohydrate intake and the water stored with it
Fat mass change	Small on any single day relative to the rows above

Fat loss is the smallest contributor to daily scale movement. This is why single weigh-ins feel random.

The solution: weigh daily, ignore the daily number, track the weekly average. Apps like Happy Scale, Libra, or a simple spreadsheet calculate rolling averages automatically. The 7-day average filters out water, stool, and glycogen noise, leaving the fat loss signal.

When to ignore the scale entirely:

• The first 2 weeks of a new exercise program (muscle inflammation and glycogen replenishment add temporary water weight)
• The week before menstruation (hormonal water retention)
• The day after a high-sodium meal (water retention)
• During acute illness (dehydration or fluid shifts distort weight)

In these windows, the scale measures everything except what you care about.

The 72-hour body mass stability model

Here's a framework for understanding short-term weight fluctuations:

Phase 1 (0 to 24 hours): Maximum variability. Scale weight swings with meal timing, hydration, bowel movements, and sleep. Single-day changes are uninterpretable.

Phase 2 (24 to 72 hours): Noise reduction. Water retention from a high-sodium meal resolves. Glycogen stores stabilize. Bowel movement patterns normalize. Averaging across days smooths the noise; the 60% figure that appeared here in earlier versions was not sourced and has been removed.

Phase 3 (72+ hours): Signal emergence. By day 7, the average weight reflects actual tissue change (fat and lean mass) with minimal contamination from water and gut contents. This is the meaningful measurement window.

The implication: if you weigh yourself Monday morning and Wednesday morning and see a 2-pound difference, you know almost nothing. If you compare the Monday-to-Sunday average with the previous Monday-to-Sunday average and see a 2-pound difference, you know something real happened.

This model explains why people often report that the scale isn't moving in the first week or two of treatment and then see a sudden drop. The fat loss was happening the entire time. The scale noise just hid it until enough time passed for the trend to emerge.

When bowel changes signal a problem worth addressing

Most bowel habit changes on GLP-1 medications are transient and benign. Some are not. Contact your provider if you experience:

Red-flag symptoms (same-day contact):

• Severe abdominal pain that doesn't improve with bowel movement
• Blood in stool (bright red or black, tarry stool)
• Persistent vomiting (more than 12 hours)
• Signs of dehydration (dizziness, dark urine, dry mouth, rapid heart rate)
• Inability to pass stool or gas for 3+ days with severe cramping (possible obstruction)

Yellow-flag symptoms (contact within 48 hours):

• Diarrhea lasting more than 5 days
• Constipation lasting more than 7 days despite fiber, hydration, and stool softeners
• Weight loss faster than your provider expects, together with inability to eat normally (suggests GI side effects are limiting nutrition)
• New onset of bowel habit changes after months of stable treatment (possible unrelated GI condition)

Green-flag symptoms (monitor, no immediate action needed):

• Mild diarrhea or constipation during the first 4 weeks of treatment or after dose escalation
• Bowel movements that are more or less frequent than baseline but not causing discomfort
• Temporary bloating or gas (common during GI adaptation)

The distinction: red-flag symptoms suggest acute complications (bleeding, obstruction, severe dehydration). Yellow-flag symptoms suggest the medication's GI effects are interfering with quality of life or nutrition. Green-flag symptoms are expected adaptation responses.

Correction, September 2026: what was removed and why

As of September 5, 2026, this page was checked against PubMed, the Mounjaro and Zepbound prescribing information (both revised 08/2026), StatPearls and the NIDDK. Four cited studies could not be located and were removed: a 2023 DEXA study (Müller et al.), a 2021 continuous-weighing study (Edholm et al.), a 2023 Diabetes Care gastric-emptying paper (Davies et al.), and a 1991 Cancer Research stool-weight study (Rose et al., which was a misattribution of the 2015 Rose systematic review). Every pound figure that could not be traced to a published source was removed, including the 2 to 5 pound constipation masking range, the 3 to 6 pound overnight drop, the 3 to 7 pound exercise and 2 to 5 pound menstrual water figures, the 5 to 10 calorie cost of a bowel movement, the 60% accuracy claim for 3-day averages and a 48 to 96 hour GLP-1 transit estimate. Constipation and diarrhea rates now come from the labels, and a percentage attributed to FormBlends patient data was removed because it was not drawn from an audited dataset.

GLP-1 bowel effects by the label (Zepbound and Mounjaro, revised 08/2026)

These are the gastrointestinal adverse reaction rates from the two tirzepatide labels, both revised 08/2026. Zepbound figures are from the pooled placebo-controlled weight-management trials; Mounjaro figures are from the pooled placebo-controlled type 2 diabetes trials.

Adverse reaction	Zepbound 5 / 10 / 15 mg	Zepbound placebo	Mounjaro 5 / 10 / 15 mg	Mounjaro placebo
Diarrhea	19% / 21% / 23%	8%	12% / 13% / 17%	9%
Constipation	17% / 14% / 11%	5%	6% / 6% / 7%	1%
Nausea	25% / 29% / 28%	8%	12% / 15% / 18%	4%
Vomiting	8% / 11% / 13%	2%	5% / 5% / 9%	2%
Abdominal pain	9% / 9% / 10%	5%	6% / 5% / 5%	4%

On timing, the labels report that tirzepatide's delay of gastric emptying is greatest with the first dose (peak acetaminophen exposure reduced by about 50% after the first 5 mg dose) and has no meaningful impact by week 4, consistent with Urva et al. (Diabetes, Obesity and Metabolism 2020), who described the delay as transient. That is why bowel changes cluster around starting and dose increases.

Constipation defined (NIDDK) and when to call

The National Institute of Diabetes and Digestive and Kidney Diseases defines constipation as fewer than three bowel movements a week, or stools that are hard, dry, lumpy or difficult or painful to pass. It estimates that about 16 of every 100 US adults have constipation symptoms, rising to about 33 of every 100 adults aged 60 and older, so a baseline of occasional constipation is common before any medication is involved. On tirzepatide the label adds 6 to 12 percentage points above placebo depending on the product and dose (see the table above). What this page does not do, as of September 2026, is give over-the-counter product doses; ask a provider or pharmacist, who can account for your medication, dose and other conditions. The red-flag list in the section on when bowel changes signal a problem still applies: severe abdominal pain, blood in the stool, persistent vomiting, signs of dehydration, or inability to pass stool or gas with cramping all warrant same-day contact.

FAQ

Does pooping make you lose weight?

Pooping reduces scale weight temporarily by the weight of the stool, a median of about 128 grams (0.28 pounds) a day across 1.2 movements in a 2015 systematic review (Rose et al.), but this is waste elimination, not fat loss. The weight returns as you eat and drink. True weight loss requires burning stored fat through sustained caloric deficit.

How much weight do you lose when you poop?

Published medians are 128 grams (0.28 pounds) of stool a day worldwide (Rose et al., 2015 systematic review) and 106 grams a day in 220 UK adults (Cummings et al., Gastroenterology 1992), usually across one or two movements. Output rises with fiber intake, differs by sex (men 162 versus women 83 grams a day in Stephen et al., 1986), and accumulates with days since the last movement.

Can you lose belly fat by pooping more?

No. Pooping eliminates waste from the colon, not fat from adipose tissue. Belly fat is stored energy that requires caloric deficit to burn. Bowel movement frequency doesn't affect fat oxidation rates.

Why does the scale go down after I poop?

The scale measures total body mass, including gut contents. When you eliminate stool, total mass decreases by the weight of the stool, on the order of a quarter pound for a typical movement given the published median of 128 grams a day (Rose et al., 2015). This is temporary and reverses as you eat throughout the day.

Do GLP-1 medications like semaglutide make you poop more?

Often, in either direction. In the Zepbound label's pooled trials (revised 08/2026), diarrhea was reported by 19% to 23% of patients on 5 to 15 mg versus 8% on placebo, and constipation by 11% to 17% versus 5%. The labels describe gastrointestinal events as occurring mostly during dose escalation. Correction, September 2026: an unsourced 60% figure and an 8 to 12 week timeline were removed.

Does constipation prevent weight loss?

Constipation doesn't prevent fat loss, but it masks fat loss on the scale. Retained stool adds its own mass; at the published median of about 128 grams a day (Rose et al., 2015), five days without a movement is roughly 1.4 pounds before any water shift, which can offset or hide the scale drop from fat loss. Addressing constipation reveals the underlying progress.

Should I weigh myself before or after pooping?

Weigh yourself at the same time every day for consistency. Most people choose morning, post-bowel movement, fasted. The specific timing matters less than consistency. Daily fluctuations are noise; weekly trends are signal.

How long does food stay in your body before you poop it out?

Whole-gut transit time had a median of 60 hours in 220 healthy UK adults (55 hours in men, 72 in women) in Cummings et al., Gastroenterology 1992. GLP-1 medications slow stomach emptying, most at the first dose and fading by week 4 per the tirzepatide labels, but no published figure gives a total transit time on these drugs. Fiber-rich diets shorten transit.

Can diarrhea cause real weight loss?

Severe diarrhea causes dehydration and temporary scale weight loss (water and electrolytes), not fat loss. Chronic diarrhea can cause malnutrition and unintended fat and muscle loss if it prevents adequate calorie absorption, which requires medical evaluation.

Why did I gain weight even though I pooped?

Scale weight is the sum of fat, muscle, water, and gut contents. Pooping reduces gut contents, but if you gained water weight (from sodium, hormones, or exercise) or ate a large meal, total weight can still increase. Focus on weekly trends, not daily changes.

Does fiber make you lose weight by making you poop more?

Fiber increases stool bulk and frequency, which causes larger temporary scale drops after bowel movements. But fiber doesn't increase fat loss directly. Its weight-loss benefit comes from increased satiety and reduced calorie absorption, not from pooping more.

How much does poop weigh on a GLP-1 medication?

No study has weighed stool on GLP-1 medications. What is known: stool is about 75% water (Rose et al., 2015), so diarrhea makes each movement heavier and constipation reduces frequency while the retained mass accumulates. The Zepbound label (revised 08/2026) reports diarrhea in 19% to 23% and constipation in 11% to 17% of patients on 5 to 15 mg.

Is it normal to poop less on semaglutide or tirzepatide?

Yes, for a minority. The Zepbound label (revised 08/2026) reports constipation in 17%, 14% and 11% of patients at 5, 10 and 15 mg versus 5% on placebo; the Mounjaro label reports 6% to 7% versus 1%. Fluids, fiber and activity are the usual first steps; ask your provider or pharmacist before adding a stool softener or laxative.

Does pooping burn calories?

Not meaningfully. No published measurement of the energy cost of a bowel movement was located for this update, so an earlier calorie figure has been removed. The stool itself contains minimal caloric value because your body already absorbed usable energy in the small intestine. Pooping doesn't contribute meaningfully to caloric expenditure.

Why do I weigh less in the morning after pooping?

Morning weight is lowest because you've fasted overnight (no food or water intake for 10 to 12 hours), lost water through respiration and perspiration, and often have a bowel movement. This is your most consistent weigh-in time, and it will read lower than an evening weigh-in by whatever food and fluid you take in during the day.

What counts as constipation?

The NIDDK defines it as fewer than three bowel movements a week, or stools that are hard, dry, lumpy, or difficult or painful to pass. About 16 of every 100 US adults have symptoms, and about 33 of every 100 adults aged 60 and older. On tirzepatide, the Zepbound label (revised 08/2026) reports constipation in 11% to 17% of patients versus 5% on placebo, so the medication adds to a common baseline rather than creating a new problem.

How much does stool output differ between men and women?

Noticeably. In Stephen et al. (British Journal of Nutrition 1986, 30 healthy subjects), men passed 162 grams a day and women 83 grams a day. In Cummings et al. (Gastroenterology 1992, 220 UK adults), medians were 104 grams for men and 99 for women, but 17% of women versus 1% of men passed under 50 grams a day, and whole-gut transit was 72 hours in women versus 55 in men. Lower output means smaller post-bathroom scale changes.

Does the slowed stomach emptying from GLP-1 drugs last?

Mostly no. The Mounjaro and Zepbound labels (revised 08/2026) report that after the first 5 mg dose tirzepatide reduced peak acetaminophen exposure by about 50%, a marker of slowed gastric emptying, but that by week 4 there was no meaningful impact. Urva et al. (Diabetes, Obesity and Metabolism 2020) likewise described the delay as transient. That pattern explains why bowel changes cluster at the start of treatment and after dose increases.

Related guides

• Can Pooping Make You Lose Weight? The Uncomfortable Truth About Bowel Movements and Body Mass
• Does Pooping Make You Lose Weight? The Actual Science Behind Bowel Movements and Body Mass
• Does Pooping Help You Lose Weight? The Uncomfortable Truth About Bowel Movements and Fat Loss
• Can Pooping Help You Lose Weight? The Actual Science Behind Bowel Movements and Fat Loss
• Does Defecating Help You Lose Weight? The Honest Answer About Bowel Movements and the Scale
• Why Does Ozempic Make You Lose Weight? The Complete Mechanism Behind Semaglutide's Effect on Body Mass
• Tool: BMI calculator

Sources

1. Cummings JH et al. Fecal weight, colon cancer risk, and dietary intake of nonstarch polysaccharides (dietary fiber). Gastroenterology. 1992;103:1783-1789, PMID 1333426.
2. Stephen AM et al. Effect of wheat fibre on stool weight and bowel function in healthy subjects. British Journal of Nutrition. 1986;56:349-361, PMID 2823871.
3. Burkitt DP et al. Effect of dietary fibre on stools and transit-times. Lancet. 1972.
4. Jastreboff AM et al. Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1). New England Journal of Medicine. 2022.
5. Nauck MA et al. GLP-1 receptor agonists in the treatment of type 2 diabetes: state-of-the-art. Molecular Metabolism. 2021.
6. Camilleri M et al. Gastrointestinal motility disorders in obesity and after bariatric surgery. Gastroenterology. 2020.
7. Halawi H et al. Effects of liraglutide on weight, satiation, and gastric functions in obesity. Obesity. 2017.
8. Acosta A et al. Quantitative gastrointestinal and psychological traits associated with obesity and response to weight-loss therapy. Gastroenterology. 2015.
9. Greenway FL et al. Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I). Lancet. 2010.
10. American College of Gastroenterology. Guidelines for the diagnosis and management of gastroesophageal reflux disease. American Journal of Gastroenterology. 2022.
11. Rose C, Parker A, Jefferson B, Cartmell E. The Characterization of Feces and Urine: A Review of the Literature to Inform Advanced Treatment Technology. Crit Rev Environ Sci Technol 2015;45:1827-1879, PMID 26246784 (median wet mass 128 g/day, 74.6% water, 1.20 defecations/day).
12. StatPearls. Physiology, Defecation (composition of feces: 75% water; solids 30% undigested food, 30% bacteria, 10-20% inorganic, 10-20% fat, 2-3% protein), updated November 13, 2023. https://www.ncbi.nlm.nih.gov/books/NBK539732/
13. National Institute of Diabetes and Digestive and Kidney Diseases. Definition and Facts for Constipation (fewer than three bowel movements a week; about 16 of 100 adults), last reviewed May 2018. https://www.niddk.nih.gov/health-information/digestive-diseases/constipation/definition-facts
14. Urva S et al. The novel dual GIP and GLP-1 receptor agonist tirzepatide transiently delays gastric emptying similarly to selective long-acting GLP-1 receptor agonists. Diabetes Obes Metab 2020;22:1886-1891, PMID 32519795.
15. Eli Lilly and Company. Zepbound (tirzepatide) Prescribing Information, adverse reactions table and clinical pharmacology, revised 08/2026. https://pi.lilly.com/us/zepbound-uspi.pdf
16. Eli Lilly and Company. Mounjaro (tirzepatide) Prescribing Information, adverse reactions table and clinical pharmacology, revised 08/2026. https://pi.lilly.com/us/mounjaro-uspi.pdf
17. Burkitt DP, Walker AR, Painter NS. Effect of dietary fibre on stools and the transit-times, and its role in the causation of disease. Lancet 1972;2(7792):1408-1412, PMID 4118696 (figures not verified for this update).

Footer disclaimers

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Ozempic, Wegovy, Mounjaro, and Zepbound are registered trademarks of their respective manufacturers. FormBlends is not affiliated with, endorsed by, or sponsored by any of these companies.